浅谈失眠的中西医结合治疗研究进展
A Brief Discussion on the Research Progress of Integrated Traditional Chinese and Western Medicine Treatment for Insomnia
摘要: 失眠作为临床最常见的睡眠障碍性疾病之一,以入睡困难、睡眠维持障碍或早醒为主要表现,常伴有注意力、记忆力、情绪调控等能力损害。随着现代社会节奏加快、压力增加,全球范围内失眠的患病率已达30%~40%,其中中国成人失眠发生率约为38.2%,且呈逐年上升的趋势。长期失眠不仅会导致注意力不集中、记忆力减退等认知功能下降,还与焦虑症、抑郁症、高血压、糖尿病等慢性疾病的发生发展存在明确的关联。近年来,单一中医或西医治疗均存在一定局限性,西医的苯二氮䓬类、非苯二氮䓬类等传统镇静催眠药物,虽能快速改善入睡困难等症状,但长期使用易出现耐药性、依赖性、反跳性失眠,甚至可能加重认知功能损害;而单纯中医治疗的显效速度相对较慢,对重度失眠的单药控制率不足50%,难以满足临床中部分患者的治疗需求。因此,中西医结合治疗逐渐成为失眠研究的热点,本文就失眠的中西医结合治疗进行论述,现综述如下。
Abstract: Insomnia, as one of the most common sleep disorders in clinical practice, is primarily characterized by difficulty falling asleep, impaired sleep maintenance, or early awakening, often accompanied by impairments in attention, memory, and emotional regulation. With the accelerated pace and increased pressure of modern society, the prevalence of insomnia has reached 30%~40% globally, with an incidence rate of approximately 38.2% among Chinese adults, showing a trend of increasing year by year. Long-term insomnia not only leads to cognitive decline such as impaired attention and memory, but also has a clear association with the occurrence and development of chronic diseases such as anxiety, depression, hypertension, and diabetes. In recent years, both traditional Chinese medicine (TCM) and Western medicine treatments have shown certain limitations. Traditional sedative and hypnotic drugs such as benzodiazepines and non-benzodiazepines in Western medicine can rapidly improve symptoms such as difficulty falling asleep, but long-term use can lead to drug resistance, dependence, rebound insomnia, and even exacerbate cognitive impairment. Conversely, TCM treatment alone has a relatively slow onset of efficacy, with a single-drug control rate of less than 50% for severe insomnia, making it difficult to meet the treatment needs of some patients in clinical practice. Therefore, the integration of TCM and Western medicine has gradually become a hotspot in insomnia research. This article discusses the integrated TCM and Western medicine treatment for insomnia and provides a review as follows.
参考文献
|
[1]
|
高钰, 王蒙, 李宇曦, 等. 基于“脾为之卫”理论从“肠道菌群-昼夜节律-营卫循行”论治慢性失眠[J]. 中医杂志, 2026, 67(6): 619-624.
|
|
[2]
|
王艳锋, 张彦敏, 王醊恩, 等. 柏子养心丸对心脾两虚型亚健康学生失眠干预作用分析[J]. 辽宁中医杂志, 2026, 53(3): 118-121.
|
|
[3]
|
丁昱峤, 张烨. 入睡困难型失眠症病因病机及辨证论治探讨[J]. 湖北中医药大学学报, 2022, 24(4): 55-58.
|
|
[4]
|
陈悦, 孙美杰, 冯乐伟. 基于少阳主枢理论探讨针灸治疗肝郁气滞型失眠患者的疗效及对GABA、CORT水平的影响[J]. 检验医学与临床, 2025, 22(23): 3192-3197.
|
|
[5]
|
王晓晴. 基于HPA轴通路探讨益肾养心安神片对失眠性应激模型大鼠学习记忆障碍的作用机制[D]: [硕士学位论文]. 承德: 承德医学院, 2024.
|
|
[6]
|
潘夏彦, 荆桧, 张彬. 失眠的中西医病因病机浅析[J]. 中国中医药现代远程教育, 2025, 23(2): 144-147.
|
|
[7]
|
杨思雨, 冷秀梅, 刘晋, 等. 酸枣仁汤合黄连温胆汤治疗成人慢性失眠症及辅助苯二氮卓类药物撤药的作用: 一项多中心、前瞻性队列研究[J]. 南京中医药大学学报, 2023, 39(12): 1224-1231.
|
|
[8]
|
杜鹤, 刘佳星, 闫艳, 等. 整合代谢组学与肠道菌群分析酸枣仁汤改善失眠大鼠的作用机制[J]. 中国中药杂志, 2022, 47(24): 6741-6752.
|
|
[9]
|
Li, W., Wang, Q., Dang, C., Xiong, Y. and Lu, Y. (2025) Chinese Herbal Medicine for Insomnia: A Systematic Review and Network Meta-Analysis. Medicine, 104, e43789. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
客在敬. 乌灵胶囊联合佐匹克隆治疗原发性失眠的临床疗效观察[J]. 世界睡眠医学杂志, 2025, 12(1): 115-118.
|
|
[11]
|
杜耀峰, 李元元, 张鼎, 等. 肉蔻五味丸联合盐酸曲唑酮治疗围绝经期患者失眠伴焦虑抑郁的临床研究[J]. 现代中医药, 2023, 43(5): 92-96.
|
|
[12]
|
王业群, 方无杰, 项尚, 等. 解郁清心配方颗粒联合远程交互式CBT-I治疗肝郁化火型慢性失眠的临床疗效[J]. 中国实验方剂学杂志, 2024, 30(20): 120-126.
|
|
[13]
|
朱文娟. 健脾通络方针灸联合认知行为疗法对胃癌术后化疗失眠患者的应用效果[J]. 世界睡眠医学杂志, 2025, 12(6): 1282-1284+1288.
|